OTC · CIK 0001922335
SYRA Syra Health Corp
Insider trading from SEC Form 4. Last filing 15 d ago.
Syra Health Corp (SYRA) has 14 SEC Form 4 filings on file from 7 insiders, the latest filed on Sep 28, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Syra Health Corp, scored.
Transactions
Every row filed, 20 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Gregory R. Alexander CEO | AGrant or award Performance Stock Unitsderivative | +368,458 | $0.00 | $0 | 368,458 | 15 d ago |
| Aug 31, 2026 | Priya Prasad COO and CFO | AGrant or award Performance Stock Unitsderivative | +86,696 | $0.00 | $0 | 86,696 | 15 d ago |
| Jan 5, 2026 | Gregory R. Alexander CEO | AGrant or award Restricted Stock Units | +110,537 | $0.00 | $0 | 110,537 | 15 d ago |
| Aug 31, 2026 | Priya Prasad COO and CFO | AGrant or award Stock Optionsderivative | +60,687 | $0.00 | $0 | 60,687 | 15 d ago |
| Jan 5, 2026 | Gregory R. Alexander CEO | AGrant or award Stock Optionsderivative | +257,920 | $0.00 | $0 | 257,920 | 15 d ago |
| Aug 31, 2026 | Priya Prasad COO and CFO | AGrant or award Restricted Stock Unitsderivative | +26,009 | $0.00 | $0 | 26,009 | 15 d ago |
| Aug 31, 2026 | Priya Prasad COO and CFO | AGrant or award Performance Stock Unitsderivative | +86,696 | $0.00 | $0 | 86,696 | 41 d ago |
| Aug 31, 2026 | Priya Prasad COO and CFO | AGrant or award Stock Optionsderivative | +60,687 | $0.00 | $0 | 60,687 | 41 d ago |
| Aug 31, 2026 | Priya Prasad COO and CFO | AGrant or award Restricted Stock Unitsderivative | +26,009 | $0.00 | $0 | 26,009 | 41 d ago |
| Jan 5, 2026 | Gregory R. Alexander CEO | AGrant or award Restricted Stock Units | +110,537 | $0.00 | $0 | 110,537 | Feb 3, 2026 |
| Jan 5, 2026 | Gregory R. Alexander CEO | AGrant or award Stock Optionsderivative | +257,920 | $0.00 | $0 | 257,920 | Feb 3, 2026 |
| Nov 21, 2025 | Ketan Paranjape director | AGrant or award Stock Optionsderivative | +43,348 | $0.00 | $0 | 77,821 | Nov 25, 2025 |
| Nov 21, 2025 | Avutu Reddy director | AGrant or award Stock Optionsderivative | +43,348 | $0.00 | $0 | 70,926 | Nov 25, 2025 |
| Nov 21, 2025 | Vijayapal Reddy director | AGrant or award Stock Optionsderivative | +43,348 | $0.00 | $0 | 70,926 | Nov 25, 2025 |
| Jan 7, 2025 | Andrew Dahlem director | AGrant or award Stock Optionsderivative | +9,102 | $0.00 | $0 | 20,683 | Jan 8, 2025 |
| Nov 14, 2024 | Andrew Dahlem director | AGrant or award Stock Optionsderivative | +11,581 | $0.00 | $0 | 11,581 | Nov 18, 2024 |
| Nov 14, 2024 | Ketan Paranjape director | AGrant or award Stock Optionsderivative | +19,303 | $0.00 | $0 | 19,303 | Nov 18, 2024 |
| Nov 14, 2024 | Avutu Reddy director | AGrant or award Stock Optionsderivative | +15,442 | $0.00 | $0 | 15,442 | Nov 18, 2024 |
| Nov 14, 2024 | Vijayapal Reddy director | AGrant or award Stock Optionsderivative | +15,442 | $0.00 | $0 | 15,442 | Nov 18, 2024 |
| Nov 14, 2024 | Sherron Rogers director | AGrant or award Stock Optionsderivative | +11,581 | $0.00 | $0 | 11,581 | Nov 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Gregory R. AlexanderCEO
- Andrew Dahlemdirector
- Ketan Paranjapedirector
- Priya PrasadCOO and CFO
- Avutu Reddydirector
- Vijayapal Reddydirector
- Sherron Rogersdirector
Questions about SYRA
Answered from the filings on this page, as of the latest one.
Are insiders buying SYRA?
No. In the last 90 days no insider at Syra Health Corp bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SYRA on the open market?
No open-market trade has been scored at Syra Health Corp. The latest Form 4 on file was filed on Sep 28, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Syra Health Corp?
7 people have filed a Form 4 at Syra Health Corp, among them Gregory R. Alexander (CEO), Andrew Dahlem (director), Ketan Paranjape (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.